価格表

在庫・価格 : 2025年04月29日 11時02分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-uPA Receptor, Human, Goat-Poly <Anti-uPAR>
データシート※最新のデータシートでない場合があります
AF807 RSDアールアンドディー システムズ
R&D Systems, Inc.
100 μg ¥106,000
(未発注)
追加

在庫・価格 : 2025年04月29日 11時02分 現在

Anti-uPA Receptor, Human, Goat-Poly <Anti-uPAR>

  • 商品コード:AF807
  • メーカー:RSD
  • 包装:100μg
  • 価格: ¥106,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Memarzadeh S et al. Urokinase plasminogen activator receptor: Prognostic biomarker for endometrial cancer. Proc. Natl. Acad. Sci. U.S.A. 2002 Aug;99(16):10647-52
Memarzadeh S et al
2002/01/01
Species: Human, Application: IHC Paraffin-embedded, Sample type: Whole Tissue PubMed
2 Joseph K et al. Interaction of high molecular weight kininogen binding proteins on endothelial cells. Thromb. Haemost. 2004 Jan;91(1):61-70
Joseph K et al
2004/01/01
Species: Human, Application: Western Blot, Sample type: recombinant UPAR/Cytokeratin 1 complex PubMed
3 Pai R et al. Deoxycholic acid activates beta-catenin signaling pathway and increases colon cell cancer growth and invasiveness. Mol. Biol. Cell 2004 May;15(5):2156-63
Pai R et al
2004/01/01
Application: Neutralization, Sample Type: Whole Cells PubMed
4 Mace KA et al. HOXA3 induces cell migration in endothelial and epithelial cells promoting angiogenesis and wound repair. J. Cell. Sci. 2005 Jun;118(Pt 12):2567-77
Mace KA et al
2005/01/01
Application: Western Blot, Sample Type: Cell Lysates PubMed
5 Kondraganti S et al. RNAi-mediated downregulation of urokinase plasminogen activator and its receptor in human meningioma cells inhibits tumor invasion and growth. Int. J. Oncol. 2006 Jun;28(6):1353-60
Kondraganti S et al
2006/01/01
Application: Western Blot, Sample Type: Cell Lysates PubMed
6 Jiang M et al. Pitavastatin attenuates the PDGF-induced LR11/uPA receptor-mediated migration of smooth muscle cells. Biochem. Biophys. Res. Commun. 2006 Oct;348(4):1367-77
Jiang M et al
2006/01/01
Application: Western Blot, Sample Type: Cell Lysates PubMed
7 Kunigal S et al. RNAi-mediated downregulation of urokinase plasminogen activator receptor and matrix metalloprotease-9 in human breast cancer cells results in decreased tumor invasion, angiogenesis and growth. Int. J. Cancer 2007 Nov;121(10):2307-16
Kunigal S et al
2007/01/01
Species: Human, Application: Western Blot, Sample type: Cell Lysates PubMed
8 Wei C et al. Modification of kidney barrier function by the urokinase receptor. Nat. Med. 2008 Jan;14(1):55-63
Wei C et al
2008/01/01
Species: Human, Application: IHC Unspecified, Sample type: Whole Cells, Whole Tissue PubMed
9 Jiang M et al. Ang II-stimulated migration of vascular smooth muscle cells is dependent on LR11 in mice. J. Clin. Invest. 2008 Aug;118(8):2733-46
Jiang M et al
2008/01/01
Species: Mouse, Application: Immunoprecipitation, Neutralization, Western Blot, Cell Lysates, In Vivo PubMed
10 Annis MG et al. Integrin-uPAR signaling leads to FRA-1 phosphorylation and enhanced breast cancer invasion. Breast Cancer Res. 2018 01;20(1):9
Annis MG et al
2018/01/01
PubMed
  • No.: 1
  • 文献情報:
    Memarzadeh S et al. Urokinase plasminogen activator receptor: Prognostic biomarker for endometrial cancer. Proc. Natl. Acad. Sci. U.S.A. 2002 Aug;99(16):10647-52
    Memarzadeh S et al
    2002/01/01
  • 備考:
    Species: Human, Application: IHC Paraffin-embedded, Sample type: Whole Tissue
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Joseph K et al. Interaction of high molecular weight kininogen binding proteins on endothelial cells. Thromb. Haemost. 2004 Jan;91(1):61-70
    Joseph K et al
    2004/01/01
  • 備考:
    Species: Human, Application: Western Blot, Sample type: recombinant UPAR/Cytokeratin 1 complex
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Pai R et al. Deoxycholic acid activates beta-catenin signaling pathway and increases colon cell cancer growth and invasiveness. Mol. Biol. Cell 2004 May;15(5):2156-63
    Pai R et al
    2004/01/01
  • 備考:
    Application: Neutralization, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Mace KA et al. HOXA3 induces cell migration in endothelial and epithelial cells promoting angiogenesis and wound repair. J. Cell. Sci. 2005 Jun;118(Pt 12):2567-77
    Mace KA et al
    2005/01/01
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Kondraganti S et al. RNAi-mediated downregulation of urokinase plasminogen activator and its receptor in human meningioma cells inhibits tumor invasion and growth. Int. J. Oncol. 2006 Jun;28(6):1353-60
    Kondraganti S et al
    2006/01/01
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Jiang M et al. Pitavastatin attenuates the PDGF-induced LR11/uPA receptor-mediated migration of smooth muscle cells. Biochem. Biophys. Res. Commun. 2006 Oct;348(4):1367-77
    Jiang M et al
    2006/01/01
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Kunigal S et al. RNAi-mediated downregulation of urokinase plasminogen activator receptor and matrix metalloprotease-9 in human breast cancer cells results in decreased tumor invasion, angiogenesis and growth. Int. J. Cancer 2007 Nov;121(10):2307-16
    Kunigal S et al
    2007/01/01
  • 備考:
    Species: Human, Application: Western Blot, Sample type: Cell Lysates
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Wei C et al. Modification of kidney barrier function by the urokinase receptor. Nat. Med. 2008 Jan;14(1):55-63
    Wei C et al
    2008/01/01
  • 備考:
    Species: Human, Application: IHC Unspecified, Sample type: Whole Cells, Whole Tissue
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Jiang M et al. Ang II-stimulated migration of vascular smooth muscle cells is dependent on LR11 in mice. J. Clin. Invest. 2008 Aug;118(8):2733-46
    Jiang M et al
    2008/01/01
  • 備考:
    Species: Mouse, Application: Immunoprecipitation, Neutralization, Western Blot, Cell Lysates, In Vivo
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Annis MG et al. Integrin-uPAR signaling leads to FRA-1 phosphorylation and enhanced breast cancer invasion. Breast Cancer Res. 2018 01;20(1):9
    Annis MG et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed